HCMC · Healthier Choices Management Corp.
$0.00
At close · Aug 26
Going-concern doubt
— cleared Aug 19, 2026
The latest filing states the doubt was alleviated.
“Management believes that the Company’s cash on hand, together with the availability of up to $4.5 million in additional draws under the Sabby Loan Agreement, and the $50,000 in proceeds received on June 26, 2026 (with the formal loan agreement executed on July 6, 2026), will enable the Company to meet its obligations and capital requirements for at least twelve months from the date these financial statements are issued. Accordingly, no adjustment has been made to the financial statements to account for this uncertainty.”View the 10-Q filed Aug 19, 2026
Market Cap
$52.72M
Shares
527.16B
HCMC metrics
47 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.00
Market cap
$52.72M
Price action
19 metricsPrice change (1W)
+0.0%
Price change (30D)
-100.0%
Price change (3M)
+0.0%
Price change (6M)
—
Price change (YTD)
+0.0%
Price change (1Y)
—
Trailing year
Price change (5Y)
-87.5%
52-week high
$0.00
52-week low
$0.00
Change from 52-week high
+0.0%
Change from 52-week low
+0.0%
Annualized volatility
—
Beta
—
RSI (14D)
—
Price vs SMA 50
+0.0%
Price vs SMA 200
-8.3%
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—
Company
3 metricsSector
Consumer Defensive
Industry
Tobacco
Shares outstanding
527.16B
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
17,695.8×
reciprocal yield 0.0%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-6.7%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.2×
reciprocal yield 44.9%
EV / revenue historical average (5Y)
7.5×
reciprocal yield 13.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
-937.9%
Operating margin
-236,084.2%
Trailing 12 months
Net margin
-235,580.6%
Gross profit (TTM)
−$27,941
Operating profit (TTM)
−$3.58M
Net income (TTM)
−$3.55M
Trailing 12 months
Diluted EPS (TTM)
$0.00
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2,979
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+9.5%
Year over year · more shares
Revenue CAGR (3Y)
-95.3%
Revenue CAGR (5Y)
-81.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-237.8%
Debt / equity
—
Current ratio
0.7
EBITDA (TTM)
−$3.54M
Free cash flow (TTM)
—
Quick ratio
0.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.20M
Total assets
$1.49M
Total debt
$4.98M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$2.51M
Capital expenditures (TTM)
$83,508
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$3.40M
R&D / revenue
—
Stock compensation / revenue
113,982.1%
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
11 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—